Oeg Pharma Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
as on 31-07-2024
- Paid Up Capital ₹ 3.00 M
as on 31-07-2024
- Company Age 7 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 9.50 M
as on 31-07-2024
- Revenue %
(FY 2023)
- Profit 52.54%
(FY 2023)
- Ebitda 49.25%
(FY 2023)
- Net Worth -3.51%
(FY 2023)
- Total Assets -7.14%
(FY 2023)
About Oeg Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 3.00 M.
The company currently has active open charges totaling ₹9.50 M.
Subramanyam Ramesh, Ramesh Sudarshan, and Ramesh Vijay serve as directors at the Company.
- CIN/LLPIN
U33309TN2017PTC117598
- Company No.
117598
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Jul 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Oeg Pharma?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Subramanyam Ramesh  | Director | 17-Jul-2017 | Current |
| Ramesh Sudarshan | Director | 17-Jul-2017 | Current |
| Ramesh Vijay | Director | 25-Sep-2020 | Current |
Financial Performance and Corporate Structure Insights of Oeg Pharma.
Oeg Pharma Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 52.54% increase in profit. The company's net worth dipped by a decrease of 3.51%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Oeg Pharma?
In 2023, Oeg Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Pacific Technical Services India Private LimitedActive 31 years 11 monthsSubramanyam Ramesh and Ramesh Vijay are mutual person
Pacific Supplies Private LimitedActive 30 years 8 monthsSubramanyam Ramesh and Ramesh Vijay are mutual person
Operational Energy Group India LimitedActive 30 years 4 monthsSubramanyam Ramesh is a mutual person
South Ganga Waters Technologies Private LimitedActive 20 years 5 monthsRamesh Sudarshan and Ramesh Vijay are mutual person
Oeg Solar Energy Private LimitedActive 18 years 8 monthsSubramanyam Ramesh and Ramesh Vijay are mutual person
Oeg Agrofarms Private LimitedActive 1 month 5 daysSubramanyam Ramesh, Ramesh Sudarshan and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 24 Jan 2018 | ₹9.50 M | Open |
How Many Employees Work at Oeg Pharma?
Unlock and access historical data on people associated with Oeg Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Oeg Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Oeg Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
